Rituximab is a monoclonal antibody that primarily targets the CD20 protein found on the surface of B cells. It is widely used in the treatment of various autoimmune diseases and certain types of cancers, including lymphomas and leukemias. In the context of gynecology, rituximab has potential applications in the management of specific conditions that involve the immune system.
